Edition:
India

Transgene SA (TRNG.PA)

TRNG.PA on Paris Stock Exchange

2.32EUR
19 Jul 2019
Change (% chg)

€-0.03 (-1.07%)
Prev Close
€2.35
Open
€2.36
Day's High
€2.36
Day's Low
€2.31
Volume
24,008
Avg. Vol
57,902
52-wk High
€3.30
52-wk Low
€2.28

Select another date:

Thu, May 2 2019

Photo

AstraZeneca ties up with France's Transgene to develop viral immunotherapies

British drugmaker AstraZeneca Plc and French biopharmaceutical firm Transgene SA entered into an agreement on Thursday to co-develop five cancer-killing viral immunotherapies.

AstraZeneca ties up with France's Transgene to develop viral immunotherapies

May 2 British drugmaker AstraZeneca Plc and French biopharmaceutical firm Transgene SA entered into an agreement on Thursday to co-develop five cancer-killing viral immunotherapies.

Select another date: